Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071840-01
Application #
2010198
Study Section
Pathology B Study Section (PTHB)
Project Start
1996-09-30
Project End
1996-12-31
Budget Start
1996-09-30
Budget End
1996-12-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Pothuri, Bhavana; Leitao, Mario M; Levine, Douglas A et al. (2010) Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One 5:e10358
King, Tari A; Li, Weiwei; Brogi, Edi et al. (2007) Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann Surg Oncol 14:2510-8
Kim, S-W; Lee, C S; Fey, J V et al. (2005) Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases. J Med Genet 42:e5
King, Tari A; Gemignani, Mary L; Li, Weiwei et al. (2004) Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. Cancer Res 64:5051-3
Leitao, Mario M; Soslow, Robert A; Baergen, Rebecca N et al. (2004) Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma. Gynecol Oncol 93:301-6
Leitao, Mario; Boyd, Jeff (2002) Preoperative CA-125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma. Gynecol Oncol 84:413-5
Levine, Douglas A; Federici, Mark G; Reuter, Victor E et al. (2002) Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer. Gynecol Oncol 85:431-4
Levine, D A; Boyd, J (2001) The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res 61:908-11
Levine, D A; Lin, O; Barakat, R R et al. (2001) Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 80:395-8
Sonoda, Y; Saigo, P E; Federici, M G et al. (2000) Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Gynecol Oncol 76:226-9

Showing the most recent 10 out of 15 publications